Jane Street’s Roivant Sciences ROIV Stock Holding History

Jane Street’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.95M	Sell	107,900 -8,700	-7%	-$315K	﹤0.01%	4073
2026 Q2	$4.13M	Sell	116,600 -17,600	-13%	-$520K	﹤0.01%	3985
2026 Q1	$3.72M	Sell	134,200 -139,500	-51%	-$3.58M	﹤0.01%	3976
2025 Q4	$5.94M	Buy	273,700 +13,800	+5%	+$272K	﹤0.01%	2973
2025 Q3	$3.93M	Buy	259,900 +238,000	+1,087%	+$2.95M	﹤0.01%	3783
2025 Q2	$247K	Sell	21,900 -4,200	-16%	-$45.5K	﹤0.01%	8177
2025 Q1	$263K	Sell	26,100 -16,600	-39%	-$180K	﹤0.01%	8019
2024 Q4	$505K	Sell	42,700 -219,100	-84%	-$2.59M	﹤0.01%	6760
2024 Q3	$3.02M	Buy	261,800 +215,800	+469%	+$2.46M	﹤0.01%	3703
2024 Q2	$486K	Sell	46,000 -12,400	-21%	-$136K	﹤0.01%	7061
2024 Q1	$616K	Sell	58,400 -173,000	-75%	-$1.87M	﹤0.01%	6292
2023 Q4	$2.6M	Sell	231,400 -317,400	-58%	-$3.09M	﹤0.01%	3865
2023 Q3	$6.41M	Buy	+548,800	New	+$6.2M	﹤0.01%	2286

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Jane Street's ROIV Position: Q3 2026 in Review

Jane Street increased its Roivant Sciences (ROIV) stake by 0.77% in Q3 2026, buying an estimated $7.87K and bringing the position to 28,422 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #6412.

Jane Street first reported a position in ROIV in Q1 2022 and has held it in 18 quarters since. The position peaked at $41.5M in Q3 2025. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

Jane Street held 28,422 shares of Roivant Sciences worth $1.04M as of Q3 2026.
Jane Street bought 217 Roivant Sciences shares in Q3 2026, an estimated $7.87K.
Roivant Sciences made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6412 holding.
Jane Street first reported a position in Roivant Sciences in Q1 2022 and has held it in 18 quarters since.
Jane Street's Roivant Sciences position peaked at $41.5M in Q3 2025.
395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.